Clinical & translational oncology

• 

  Año 2016, Vol. 18, Número 10

  • Signaling and molecular basis of bone marrow niche angiogenesis in leukemia

    R. Shirzadii, S. Shahrabi, A. Ahmadzadeh, K.R. Kampen, M. Shahjahani, N. Saki

    • Resumen

    págs. 957-971

    

  • Role of taxanes in advanced prostate cancer

    Javier Cassinello Espinosa, Luis Antón Aparicio, J.M. Rodríguez Luna

    • Resumen

    págs. 972-980

    

  • Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics

    L. Moreno, Juan Jesús Cruz Hernández, C. Linossi, M. Isabel Esteban, N. Gadea, Eva Carrasco, S. Bonache, S. Gutiérrez Enríquez, O. Díez, Judith Balmaña

    • Resumen

    págs. 981-987

    

  • Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive:: everything was not too bad back when everything seemed worse

    A. Orlandi, M.A. Calegarii, Miguel Martín Jiménez, A. Cocomazzi, C. Bagalà, G. Indellicat, V. Zurlo, M. Basso, Alessandra Cassano, L.M. Larocca, Carlo Barone

    • Resumen

    págs. 988-995

    

  • Ki-67 is a prognostic marker for hormone receptor positive tumors

    María Eva Pérez López, Jesús García Gómez, M.T. Alves, A. Paradela, Jesús García Mata, Tomás García-Caballero Parada

    • Resumen

    págs. 996-1002

    

  • Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study

    M. Trovo, N. Giaj Levra, C. Furlan, M.T. Bortolin, E. Muraro, E. Minatel, R. Tedesch, A.R. Filippi, F. Alongi, U. Ricardi, J. Poleselii

    • Resumen

    págs. 1003-1010

    

  • Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy

    Mikel Rico Osés, Enrique Martínez López, Santiago Pellejero Pellejero, Begoña Bermejo Fraile, P. Navarrete, Marta Barrado Los Arcos, M. Campo Vargas, F. Mañeru, Elena Villafranca Iturre, José Javier Aristu Mendioroz

    • Resumen

    págs. 1011-1018

    

  • Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer

    Z. Huang, Y. Ying, D. Xu, F. Zhang, L. Song

    • Resumen

    págs. 1019-1025

    

  • The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort

    A. Gómez-Iturriaga, Á. Cabeza, Jorge Rafael Pastor Peidro, J. Jové Teixidó, M. Casaña Giner, A.G. Caamaño, J.L. Mengual Cloquell, I. Henríquez, Julia Luisa Muñoz García, Asunción Hervás Morón, Carmen González San Segundo

    • Resumen

    págs. 1026-1033

    

  • Long-term visual outcomes in intraocular retinoblastoma with eye preservation

    A. Batra, N. Pushker, P. Venkatesh, T. Arora, R. Tewari, S. Bakhshi

    • Resumen

    págs. 1034-1038

    

  • Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer

    M. Nicoś, P. Krawczyk, B. Jarosz, M. Sawicki, M. Michnar, T. Trojanowski, J. Milanowski

    • Resumen

    págs. 1039-1043

    

  • Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach

    Salvador Martín Algarra, Luis de la Cruz-Merino, Virtudes Soriano Teruel, José Luis Manzano Mozo, E. Espinosa Arranz

    • Resumen

    págs. 1044-1050